About
Atterx Biotherapeutics develops novel treatments to prevent and treat antibiotic-resistant bacterial infections, focusing on catheter-associated urinary tract infections and gram-negative bacterial infections.
Explore Atterx Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.